Show Summary Details
Page of

Management of fibromyalgia syndrome 

Management of fibromyalgia syndrome
Management of fibromyalgia syndrome

Ernest Choy

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 03 April 2020

The major objective in the management of fibromyalgia syndrome is to empower patients to regain control over their life, by having a positive attitude and the ability to cope with the condition. Several evidence-based guidelines have been published to guide best practice. A combination of education, and non-pharmacological and pharmacological therapies is usually needed to achieve this goal. Although these treatments are not curative, they are important adjuvants, helping patients to cope with pain and improve their quality of life. Fibromyalgia syndrome is heterogeneous; therefore, the management strategy must be tailor-made to the individual patient, bearing in mind co-morbidities, such as depression, and potential side effects of therapy. There is moderate to strong evidence to support patient education, exercise, warm water therapy, cognitive behavioural therapy, and massage as non-pharmacological therapies. For pharmacological treatment, there is evidence to support the use of amitriptyline, tramadol, duloxetine, pregabalin, and milnacipran.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.